Verition Fund Management’s Arcus Biosciences RCUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $597K | Buy |
73,309
+3,840
| +6% | +$31.3K | ﹤0.01% | 2147 |
|
|
2025
Q1 | $545K | Buy |
69,469
+54,132
| +353% | +$425K | ﹤0.01% | 1944 |
|
|
2024
Q4 | $228K | Buy |
+15,337
| New | +$228K | ﹤0.01% | 2268 |
|
|
2024
Q3 | – | Sell |
-89,611
| Closed | -$1.36M | – | 2730 |
|
|
2024
Q2 | $1.36M | Buy |
+89,611
| New | +$1.36M | 0.01% | 1027 |
|
|
2023
Q4 | – | Sell |
-17,668
| Closed | -$317K | – | 2158 |
|
|
2023
Q3 | $317K | Buy |
+17,668
| New | +$317K | ﹤0.01% | 1396 |
|
|
2023
Q2 | – | Sell |
-357,986
| Closed | -$6.53M | – | 2184 |
|
|
2023
Q1 | $6.53M | Buy |
357,986
+332,146
| +1,285% | +$6.06M | 0.09% | 259 |
|
|
2022
Q4 | $534K | Buy |
25,840
+17,004
| +192% | +$352K | 0.01% | 987 |
|
|
2022
Q3 | $231K | Sell |
8,836
-141,660
| -94% | -$3.7M | ﹤0.01% | 1844 |
|
|
2022
Q2 | $3.81M | Buy |
+150,496
| New | +$3.81M | 0.08% | 343 |
|
|
2022
Q1 | – | Sell |
-11,455
| Closed | -$464K | – | 2184 |
|
|
2021
Q4 | $464K | Buy |
+11,455
| New | +$464K | ﹤0.01% | 1217 |
|
|
2020
Q3 | – | Sell |
-39,167
| Closed | -$969K | – | 1216 |
|
|
2020
Q2 | $969K | Sell |
39,167
-235,403
| -86% | -$5.82M | 0.03% | 361 |
|
|
2020
Q1 | $3.81M | Buy |
+274,570
| New | +$3.81M | 0.15% | 63 |
|